Diphtheria & Tetanus Toxoids & Acellular Pertussis Adsorbed & Inactivated Poliovirus Vaccine
Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis as the fifth dose in the diphtheria, tetanus, and acellular pertussis (DTaP) vaccine series and the fourth dose in the inactivated poliovirus vaccine (IPV) series in children 4 through 6 years of age whose previous DTaP vaccine doses have been with INFANRIX® and/or PEDIARIX® for the first three doses and INFANRIX® for the fourth dose.
KINRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) is a noninfectious, sterile vaccine for intramuscular administration.
Key Regulatory Milestones
06/24/2008 - licensed in the US
07/28/2014 - PDUFA goal date
11/06/2019 - FDA approval date